• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期口服二甲双胍对成年 Wistar 大鼠骨骼的影响。

Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats.

机构信息

Laboratorio de Investigaciones en Osteopatías y Metabolismo Mineral (LIOMM), Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Argentina.

Department of Physiological Sciences, University of Florida, Gainesville, Florida, USA.

出版信息

Exp Clin Endocrinol Diabetes. 2024 Oct;132(10):547-556. doi: 10.1055/a-2324-8661. Epub 2024 May 13.

DOI:10.1055/a-2324-8661
PMID:38740375
Abstract

INTRODUCTION

We previously showed that a 3-week oral metformin (MET) treatment enhances the osteogenic potential of bone marrow stromal cells (BMSCs) and improves several bone histomorphometric parameters in Wistar rats with metabolic syndrome (MetS). However, the skeletal effects of extended periods of MET need to be completely elucidated. Hence, in this study, the impact of a prolonged (3-month) MET treatment was investigated on bone architecture, histomorphometric and biomechanics variables, and osteogenic potential of BMSCs in Wistar rats with or without MetS.

MATERIALS AND METHODS

Young male Wistar rats (n=36) were randomized into four groups (n=9) that received either 20% fructose (), MET (), F plus MET treatments (), or drinking water alone (). Rats were euthanized, blood was collected, and bones were dissected and processed for peripheral quantitative computed tomography (pQCT) analysis, static and dynamic histomorphometry, and bone biomechanics. In addition, BMSCs were isolated to determine their osteogenic potential.

RESULTS

MET affected trabecular and cortical bone, altering bone architecture and biomechanics. Furthermore, MET increased the pro-resorptive profile of BMSCs. In addition, fructose-induced MetS practically did not affect the the structural or mechanical variables of the skeleton.

CONCLUSION

A 3-month treatment with MET (with or without MetS) affects bone architecture and biomechanical variables in Wistar rats.

摘要

简介

我们之前的研究表明,3 周的口服二甲双胍(MET)治疗可增强骨髓基质细胞(BMSCs)的成骨潜能,并改善代谢综合征(MetS)大鼠的几种骨组织形态计量学参数。然而,需要完全阐明 MET 延长治疗的骨骼效应。因此,在这项研究中,研究了延长(3 个月)MET 治疗对 Wistar 大鼠骨结构、组织形态计量和生物力学变量以及 BMSCs 成骨潜能的影响,无论是否存在 MetS。

材料和方法

将雄性 Wistar 大鼠(n=36)随机分为四组(n=9),分别接受 20%果糖()、MET()、F 和 MET 联合治疗()或单独饮用水()。大鼠安乐死后,采集血液,分离骨骼进行外周定量计算机断层扫描(pQCT)分析、静态和动态组织形态计量学以及骨生物力学分析。此外,分离 BMSCs 以确定其成骨潜能。

结果

MET 影响骨小梁和皮质骨,改变骨结构和生物力学。此外,MET 增加了 BMSCs 的促再吸收特征。此外,果糖诱导的 MetS 实际上对骨骼的结构或机械变量没有影响。

结论

3 个月的 MET 治疗(无论是否存在 MetS)都会影响 Wistar 大鼠的骨结构和生物力学变量。

相似文献

1
Skeletal Effects of a Prolonged Oral Metformin Treatment in Adult Wistar Rats.长期口服二甲双胍对成年 Wistar 大鼠骨骼的影响。
Exp Clin Endocrinol Diabetes. 2024 Oct;132(10):547-556. doi: 10.1055/a-2324-8661. Epub 2024 May 13.
2
Effects of fructose-induced metabolic syndrome on rat skeletal cells and tissue, and their responses to metformin treatment.果糖诱导的代谢综合征对大鼠骨骼细胞和组织的影响及其对二甲双胍治疗的反应。
Diabetes Res Clin Pract. 2017 Apr;126:202-213. doi: 10.1016/j.diabres.2017.02.011. Epub 2017 Feb 14.
3
Metformin treatment prevents experimental metabolic syndrome-induced femoral bone marrow adiposity in rats.二甲双胍治疗可预防实验性代谢综合征诱导的大鼠股骨骨髓脂肪堆积。
Rev Peru Med Exp Salud Publica. 2024 May 27;41(1):28-36. doi: 10.17843/rpmesp.2024.411.13333.
4
Effects of a metabolic syndrome induced by a fructose-rich diet on bone metabolism in rats.富含果糖的饮食诱导代谢综合征对大鼠骨代谢的影响。
Metabolism. 2014 Feb;63(2):296-305. doi: 10.1016/j.metabol.2013.11.002. Epub 2013 Nov 7.
5
Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: role of AMPK/SIRT1 activation and DPP-4 inhibition.维生素 D3 增强二甲双胍在代谢综合征大鼠模型中的肾脏保护作用:AMPK/SIRT1 激活和 DPP-4 抑制的作用。
Can J Physiol Pharmacol. 2021 Jun;99(6):685-697. doi: 10.1139/cjpp-2020-0435. Epub 2020 Oct 27.
6
Vitamin D3 potentiates the nephroprotective effects of vildagliptin-metformin combination in a rat model of metabolic syndrome.维生素 D3 增强了维格列汀-二甲双胍联合治疗代谢综合征大鼠模型的肾脏保护作用。
Fundam Clin Pharmacol. 2022 Apr;36(2):306-323. doi: 10.1111/fcp.12721. Epub 2021 Sep 10.
7
Metformin enhances osteogenic differentiation of BMSC by modulating macrophage M2 polarization.二甲双胍通过调节巨噬细胞 M2 极化增强骨髓间充质干细胞的成骨分化。
Sci Rep. 2024 Aug 31;14(1):20267. doi: 10.1038/s41598-024-71318-1.
8
Effects of metformin on the osteogenesis of alveolar BMSCs from diabetic patients and implant osseointegration in rats.二甲双胍对糖尿病患者牙槽骨 BMSCs 成骨及大鼠种植体骨整合的影响。
Oral Dis. 2022 May;28(4):1170-1180. doi: 10.1111/odi.13808. Epub 2021 Mar 9.
9
β1-adrenergic receptor but not β2 mediates osteogenic differentiation of bone marrow mesenchymal stem cells in normotensive and hypertensive rats.β1-肾上腺素能受体而非β2 介导正常血压和高血压大鼠骨髓间充质干细胞的成骨分化。
Eur J Pharmacol. 2021 Nov 15;911:174515. doi: 10.1016/j.ejphar.2021.174515. Epub 2021 Sep 20.
10
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing.抗糖尿病药物二甲双胍不会影响体内骨量或骨折愈合。
Osteoporos Int. 2013 Oct;24(10):2659-70. doi: 10.1007/s00198-013-2371-0. Epub 2013 May 4.

引用本文的文献

1
A Preclinical Investigation of Estrogenic Bone Protection in a Hypertensive Rat Model Under Gender-Affirming Hormone Therapy.在性别确认激素治疗下的高血压大鼠模型中雌激素对骨骼保护作用的临床前研究
Biology (Basel). 2025 Jun 3;14(6):650. doi: 10.3390/biology14060650.
2
Promoting Osteoblast Activity and Bone Integrity: Effects and Mechanisms.促进成骨细胞活性与骨完整性:作用及机制
Biology (Basel). 2025 May 21;14(5):582. doi: 10.3390/biology14050582.